Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Hess

Showing results (191-200 of 194) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 194 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2018
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)T Ruhstaller, P Thuss-Patience, S Hayoz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2015
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)D Koeberle, D C Betticher, R von Moos, et al.
Arthritis and Rheumatism|June 1, 1982
A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosisE M Ginzler, H S Diamond, M Weiner, et al.
Arthritis and Rheumatism|June 1, 1982
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of deathS Rosner, E M Ginzler, H S Diamond, et al.
Pageof 20

Showing results (191-200 of 194) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 194 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2018
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)T Ruhstaller, P Thuss-Patience, S Hayoz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2015
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)D Koeberle, D C Betticher, R von Moos, et al.
Arthritis and Rheumatism|June 1, 1982
A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosisE M Ginzler, H S Diamond, M Weiner, et al.
Arthritis and Rheumatism|June 1, 1982
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of deathS Rosner, E M Ginzler, H S Diamond, et al.
Pageof 20